Waystar (WAY) Investor Day 2026 summary
Event summary combining transcript, slides, and related documents.
Investor Day 2026 summary
11 Sep, 2026Strategic vision and market opportunity
Focused on transforming the healthcare revenue cycle through automation and AI, targeting a $20+ billion addressable market, with the total U.S. healthcare RCM spend at $103.3B and a $44.1B segment TAM for services and software.
Emphasizes a unified platform integrating front-end, mid-cycle, and back-end revenue cycle processes, leveraging proprietary data, deep workflow integration, and AI to deliver superior outcomes and client retention.
Pursuing organic growth, disciplined M&A, and capital return, with a focus on innovation, balance sheet strength, and shareholder value.
Broad connectivity with 5,000+ payers and 500+ EHR integrations, covering 60% of U.S. patients and 1 in 3 hospital discharges.
Multiple entry points and expansion paths across the revenue cycle, enabling both new client acquisition and expansion within existing accounts.
Technology, AI, and product innovation
AI and agentic capabilities are embedded across the revenue cycle, enabling predictive denial management, automated claim resubmission, and conversational analytics.
Proprietary payer-specific models and real-time data enable unique insights and rapid adaptation to payer rule changes.
AI-first development has accelerated product launches, exemplified by Recoupment Manager, which reduced development time by over 50% and client reconciliation time by 80%.
AltitudeAI drives monetization expansion through new product adjacencies, increased transaction volume, and performance-based pricing.
Real-time analytics and conversational tools provide actionable insights and measurable ROI for clients.
Commercial model and client relationships
Growth model is built on 97%+ gross revenue retention, strong cross-sell/upsell (60% of bookings), and new client wins (40%).
Platform enables clients to consolidate dozens of point solutions, simplifying technology stacks and driving operational efficiency.
Go-to-market strategy is tailored by segment, with dedicated teams for hospitals, ambulatory, and channel partners, supporting both large and small clients.
Trusted partnership model with advisory boards and early adopter programs ensures innovation is client-driven and validated in real-world settings.
Clients value the end-to-end approach, data-driven insights, and collaborative AI innovation, preferring integrated solutions over niche vendors.
Latest events from Waystar
- Q2 revenue up 18% to $320M, margins strong, guidance raised, and major acquisition completed.WAY
Q2 2026 - AI-powered automation and data integration drive efficiency, growth, and industry leadership.WAY
46th Annual William Blair Growth Stock Conference - All board proposals passed, including director elections and annual say-on-pay votes.WAY
AGM 2026 - Q2 revenue rose 15% to $270.7M, guidance was raised, and a $1.25B acquisition was announced.WAY
Q2 2025 - $1.25B AI-driven deal expands market by 15% and targets $15M+ in cost synergies.WAY
M&A Announcement - Q3 revenue up 22% to $240.1M, 40% EBITDA margin, $1B+ IPO, and raised full-year guidance.WAY
Q3 2024 - Q2 revenue up 20% to $234.5M, with strong margins and $1B+ debt reduction post-IPO.WAY
Q2 2024 - AI-driven healthcare payments platform achieves strong growth and industry leadership.WAY
43rd Annual J.P. Morgan Healthcare Conference 2025 - 2024 revenue up 19%, EBITDA margin 40.6%, net leverage 2.8x; 2025 targets 10% normalized growth.WAY
Q4 2024